Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Oncothyreon Inc. 

2601 Fourth Avenue
Suite 500
Seattle  Washington  98121   U.S.A.
Phone: 206-801-2100 Fax: 206-801-2101



 Company News
Oncothyreon Inc. (ONTY) Announces Presentation Of Positive ONT-380 Data At San Antonio Breast Cancer Symposium 12/12/2014 7:29:52 AM
Oncothyreon Inc. (ONTY) Strikes $300 Million Cancer Pact With Array BioPharma, Inc. (ARRY) 12/12/2014 7:26:54 AM
Oncothyreon Inc. (ONTY) To Present At Stifel 2014 Healthcare Conference 11/12/2014 10:27:11 AM
Oncothyreon Inc. (ONTY) And Celldex Therapeutics, Inc. (CLDX) Announce Initiation Of Combination Immunotherapy Clinical Trial Of ONT-10 And Varlilumab 11/11/2014 7:33:42 AM
Oncothyreon Inc. (ONTY) Reports Third Quarter 2014 Financial Results 11/7/2014 8:15:43 AM
Oncothyreon Inc. (ONTY) Announces Third Quarter 2014 Financial Results Conference Call 10/30/2014 8:43:11 AM
Oncothyreon Inc. (ONTY) Prices $40 Million Concurrent Public Offerings Of Common Stock And Preferred Stock 9/18/2014 9:37:04 AM
Oncothyreon Inc. (ONTY) Announces Proposed Public Offerings 9/18/2014 8:10:44 AM
Oncothyreon Inc. (ONTY) To Present At Rodman & Renshaw Global Investment Conference 9/3/2014 3:51:25 PM
Oncothyreon Inc. (ONTY)'s Lung Cancer Drug EMR 63325-009 Misses Primary Endpoint In Phase 1 Study 8/20/2014 6:12:35 AM